120 related articles for article (PubMed ID: 26403201)
1. The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro.
Clocchiatti A; Di Giorgio E; Viviani G; Streuli C; Sgorbissa A; Picco R; Cutano V; Brancolini C
J Cell Sci; 2015 Nov; 128(21):3961-76. PubMed ID: 26403201
[TBL] [Abstract][Full Text] [Related]
2. MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.
Di Giorgio E; Clocchiatti A; Piccinin S; Sgorbissa A; Viviani G; Peruzzo P; Romeo S; Rossi S; Dei Tos AP; Maestro R; Brancolini C
Mol Cell Biol; 2013 Nov; 33(22):4473-91. PubMed ID: 24043307
[TBL] [Abstract][Full Text] [Related]
3. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
4. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
5. The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.
Di Giorgio E; Gagliostro E; Clocchiatti A; Brancolini C
Mol Cell Biol; 2015 May; 35(9):1633-47. PubMed ID: 25733682
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
7. Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.
Baertschi S; Baur N; Lueders-Lefevre V; Voshol J; Keller H
J Biol Chem; 2014 Sep; 289(36):24995-5009. PubMed ID: 25012661
[TBL] [Abstract][Full Text] [Related]
8. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
9. Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA.
Chinellato M; Perin S; Carli A; Lastella L; Biondi B; Borsato G; Di Giorgio E; Brancolini C; Cendron L; Angelini A
J Mol Biol; 2024 May; 436(9):168541. PubMed ID: 38492719
[TBL] [Abstract][Full Text] [Related]
10. The black sheep of class IIa: HDAC7 SIKens the heart.
Travers JG; Hu T; McKinsey TA
J Clin Invest; 2020 Jun; 130(6):2811-2813. PubMed ID: 32364532
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription.
Minisini M; Di Giorgio E; Kerschbamer E; Dalla E; Faggiani M; Franforte E; Meyer-Almes FJ; Ragno R; Antonini L; Mai A; Fiorentino F; Rotili D; Chinellato M; Perin S; Cendron L; Weichenberger CX; Angelini A; Brancolini C
Nucleic Acids Res; 2022 Mar; 50(5):2566-2586. PubMed ID: 35150567
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the roles of subcellular distribution and interactions involving the MEF2 binding region, the ankyrin repeat binding motif and the catalytic site of HDAC4 in Drosophila neuronal morphogenesis.
Tan WJ; Hawley HR; Wilson SJ; Fitzsimons HL
BMC Biol; 2024 Jan; 22(1):2. PubMed ID: 38167120
[TBL] [Abstract][Full Text] [Related]
13. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
14. Tightly controlled MRTF-A activity regulates epithelial differentiation during formation of mammary acini.
Seifert A; Posern G
Breast Cancer Res; 2017 Jun; 19(1):68. PubMed ID: 28592291
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Engagement of the Histone Deacetylase IIA-Myocyte Enhancer Factor 2 Axis Improves Experimental Pulmonary Hypertension.
Sofer A; Lee S; Papangeli I; Adachi T; Hwangbo C; Comhair S; DaSilva-Jardine P; Kim J; Schwarz JJ; Erzurum SC; Chun HJ
Am J Respir Crit Care Med; 2018 Nov; 198(10):1345-1348. PubMed ID: 30106596
[No Abstract] [Full Text] [Related]
16. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7.
Chakraborty S; Reineke EL; Lam M; Li X; Liu Y; Gao C; Khurana S; Kao HY
J Biol Chem; 2006 Nov; 281(46):35070-80. PubMed ID: 16980305
[TBL] [Abstract][Full Text] [Related]
17. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
McKinsey TA; Zhang CL; Lu J; Olson EN
Nature; 2000 Nov; 408(6808):106-11. PubMed ID: 11081517
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.
Barneda-Zahonero B; Collazo O; Azagra A; Fernández-Duran I; Serra-Musach J; Islam AB; Vega-García N; Malatesta R; Camós M; Gómez A; Román-González L; Vidal A; López-Bigas N; Villanueva A; Esteller M; Parra M
Cell Death Dis; 2015 Feb; 6(2):e1635. PubMed ID: 25675295
[TBL] [Abstract][Full Text] [Related]
19. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression.
Ellis JJ; Valencia TG; Zeng H; Roberts LD; Deaton RA; Grant SR
Mol Cell Biochem; 2003 Jan; 242(1-2):153-61. PubMed ID: 12619878
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Functional Characterization of Histone Deacetylase 4 (HDAC4).
Li L; Yang XJ
Methods Mol Biol; 2016; 1436():31-45. PubMed ID: 27246207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
